Showing results (91-100 of 151) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2003
X-inactivation patch size in human female tissue confounds the assessment of tumor clonalityMarco Novelli, Antonio Cossu, Dahmane Oukrif, et al.
Frontiers in Oncology|May 24, 2021
High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort StudyGiampiero Capobianco, Elettra Tinacci, Laura Saderi, et al.
Anticancer Research|March 14, 2013
In vitro activity of the αvβ3 integrin antagonist RGDechi-hCit on malignant melanoma cellsMarina Pisano, Ivan DE Paola, Valentina Nieddu, et al.
Oncology Reports|March 23, 2011
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cellsAntonella Manca, Maria Cristina Sini, Francesco Izzo, et al.
Cells|March 6, 2021
Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma PatientsFrancesco De Logu, Francesca Galli, Romina Nassini, et al.
British Journal of Cancer|November 22, 2025
Sex and gender influence on adverse events for melanoma patients: a comprehensive review and meta-analysisAurora Gaeta, Luca Nuvoli, Chiara Doccioli, et al.
Critical Reviews in Oncology/Hematology|September 7, 2025
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future researchMaria Colombino, Grazia Palomba, Milena Casula, et al.
European Journal of Dermatology : EJD|November 29, 2017
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlationsMaria Colombino, Panagiotis Paliogiannis, Calogero Pagliarello, et al.
Diagnostics (Basel, Switzerland)|April 14, 2019
Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain MetastasesDavide Adriano Santeufemia, Giuseppe Palmieri, Antonio Cossu, et al.
BMC Cancer|November 17, 2006
Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanomaGiuseppe Palmieri, Sabrina M R Satriano, Mario Budroni, et al.
Pageof 16